Wockhardt's arm gets approval for Oxycodone Hydrochloride Oral Solution

19 Jun 2015 Evaluate

Wockhardt Bio AG, a subsidiary of Wockhardt, has reportedly received approval from US FDA for its abbreviated new drug application (ANDA) for Oxycodone Hydrochloride Oral Solution USP, 5 mg/5 mL. The Oxycodone Hydrochloride Oral Solution USP, 5 mg/5 mL, is bioequivalent and, therefore, therapeutically equivalent to the reference listed drug product (RLD), Oxycodone Hydrocodone Oral Solution, USP 5 mg/5 mL, of VistaPharm, Inc.

Wockhardt is one of the few companies with end to end integrated capabilities for its products, starting with the manufacture of the oral and sterile API’s, the dose forms and marketing through wholly owned subsidiary in the US, enabling the company to capture maximum value.

Wockhardt Share Price

1192.00 5.35 (0.45%)
20-Mar-2026 13:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1773.40
Dr. Reddys Lab 1294.50
Cipla 1256.00
Zydus Lifesciences 889.70
Lupin 2318.40
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×